FDA Import Refusal 300-4486235-6/11/1 — JANNSSEN PHARMACEUTICA N.V.
The FDA refused shipment 300-4486235-6/11/1 from JANNSSEN PHARMACEUTICA N.V. (Belgium) on Aug 15, 2017. The refused product falls under Drugs and Biologics — MONOCLONAL ANTIBODIES, N.E.C.. Cited charge: 75 This firm has 1 other import refusal on record.
Refusal details
- Date
- Aug 15, 2017
- Country
- Belgium
- Product Category
- Drugs and Biologics
- Product Code
- 64OIZ99 MONOCLONAL ANTIBODIES, N.E.C.
- Charges
- 75